ABSTRACT: Consumption of Se accumulator plants by livestock can result in Se intoxication. Recent research indicates that the Se forms most common in Se accumulator plants are selenate and Se-methylselenocysteine (MeSeCys). In this study the absorption, distribution, and elimination kinetics of Se in serum and whole blood of lambs dosed with a single oral dose of (1, 2, 3, or 4 mg Se/kg BW) of sodium selenate or MeSeCys were determined. The Se concentrations in serum and whole blood for both chemical forms of Se followed simple dose-dependent relationships. Se-methylselenocysteine was absorbed more quickly and to a greater extent in whole blood than sodium selenate, as observed by a greater peak Se concentration (C max ; P < 0.0001), and faster time to peak concentration (T max ; P < 0.0001) and rate of absorption (P < 0.0001). The rate of absorption and T max were also faster (P < 0.0001) in serum of lambs dosed with MeSeCys compared with those dosed sodium selenate at equimolar doses; however, C max in serum was greater (P < 0.0001) in lambs dosed with sodium selenate compared with those dosed MeSeCys at equimolar doses. The MeSeCys was absorbed 4 to 5 times faster into serum and 9 to 14 times faster into whole blood at equimolar Se doses. There were dose-dependent increases in the area under the curve (AUC) for Se in serum and whole blood of lambs dosed with both sodium selenate and MeSeCys. In whole blood the MeSeCys was approximately twice as bioavailable as sodium selenate at equimolar doses as observed by the AUC, whereas in serum there were no differences (P > 0.05) in AUC at the same doses. At 168 h postdosing the Se concentration in whole blood remained much greater (P < 0.0001) in lambs dosed with MeSeCys as compared with lambs dosed with sodium selenate; however, the serum Se concentrations were not different between treatments at the same time point. The results presented in this study demonstrate that there are differences between the kinetics of different selenocompounds when orally dosed to sheep. Therefore, in cases of acute selenosis, it is important to understand the chemical form to which an intoxicated animal was exposed when determining the importance and meaning of Se concentration in serum or whole blood obtained at various times postexposure.
INTRODUCTION
Selenium is an essential trace element that is required for many physiological processes. Selenium deficiency is a problem in much of the western United States (Edmonson et al., 1993) but Se can also be toxic. Because the difference between normal dietary Se concentrations and those which cause toxicosis is small, cases of acute and chronic selenosis can occur. Acute selenosis can be caused by misformulated supplements (Morrow, 1968; Smith et al., 1999) , misformulated feed mixes (Gabbedy and Dickson, 1969; Strugnell et al., 2010) , or grazing Se-accumulator plants on seleniferous soils (Fessler et al., 2003; Davis et al., 2012) . Selenium is commonly found in nonprimary accumulator forages as selenomethionine (SeMet; Rosenfeld and Beath, 1964; Whanger, 2002) . In contrast, some Se-accumulator plants such as Astragalus bisulcatus (Hook.) A. Gray (two-groove milk-vetch), A. praelongus E. Sheld. (Ellis stinking milk-vetch), and Stanleya pinnata (Pursh) Britton (desert prince's-plume) have been shown to accumulate Se predominantly as selenate and/or Se-methylselenocysteine (MeSeCys; Freeman et al., 2006) . The storage of Se in chemical forms other than SeMet allows the plant to grow on selenif-erous soils and store up to several thousand mg Se/kg without adverse effects to the plant.
The kinetics of Se using parenteral doses of selenite are reported (Blodgett and Bevill, 1987) . However, little is known concerning the kinetics of orally dosed selenate or MeSeCys, which are 2 of the chemical forms of Se in Se-accumulator plants. This information is crucial to interpret the risk of plant Se concentrations and the importance of tissue Se concentrations in potential cases of Se poisoning. Oral dose kinetics of Se compounds found in Se-accumulator plants will provide a much more accurate model that can be used to diagnose animals poisoned by ingestion of Se-accumulator plants. The objective of this study was to determine the oral dose kinetics of Se in serum and whole blood of lambs dosed with selenate and MeSeCys which are commonly found in Se-accumulator plants.
MATERIALS AND METHODS
All animal procedures in this study were approved by the Institutional Animal Care and Use Committee, Utah State University.
Care of Sheep
Thirty-six recently weaned crossbred lambs, 8 to 12 wk old, of uniform size and body condition were acclimatized for 2 wk before beginning the study. During both the acclimatization period and the study, the lambs had free access to water and long-stem hay (alfalfa/grass mixed), which contained ≤0.14 mg Se/kg , and a Se-free trace mineral block (American Stockman, KS). All animals appeared healthy and weighed between 20.1 kg and 32.7 kg, with a mean of 26.6 ± 3.0 kg.
One day before initiation of the study, the lambs were weighed, blood samples were collected, and then were randomly divided into 9 groups with 4 lambs in each group. The groups of lambs received doses of 0, 1, 2, 3, or 4 mg Se/kg BW as sodium selenate (Na 2 SeO 4 ; Sigma Aldrich, Milwaukee, WI) or 1, 2, 3, or 4 mg Se/kg BW as Se-methyl-seleno-l-cysteine hydrochloride (MeSeCys; Sigma Aldrich, Milwaukee, WI) as shown in Table 1 .
Each dose was prepared on the basis of BW of the animal, and was added to an empty 50 mL trace mineralgrade polypropylene tube. Immediately before administration of the dose, 20 mL of a 10% ethanol solution was added to the tubes and the mixture was vortexed. This preparation was immediately delivered directly into the rumen through an intragastric tube. The intragastric tube was flushed with approximately 500 mL of water to ensure that no Se remained in the tube. Lambs were monitored hourly for the first 48 h of the study and every 6 h for the next 48 h. Blood samples for serum (5 mL) and whole blood (5 mL) were collected by jugular venipuncture at 0, 10, 20, 30 min, and 1, 2, 3, 4, 6, 8, 12, 18, 24, 48, 72, 120 , and 168 h postdosing using sterile metal-free tubes (Tyco Healthcare Group LP, Mansfield, MA) with no additive and EDTA (Na 2 ), respectively. Whole blood samples were stored at 4°C until analysis. Blood samples for serum were centrifuged at 3,000 × g for 30 min at 4°C and the serum was separated and stored at -70°C until analyzed. The doses were selected to induce substantial clinical effects, and to compare the findings with earlier reports of acute selenosis (Tiwary et al., 2006) .
Selenium Analysis of Blood and Serum by Inductively Coupled Plasma Mass Spectrometer
Selenium analysis of serum and whole blood was performed using the same techniques described by Tiwary et al. (2006) . Samples were analyzed with an ELAN 6000 inductively coupled plasma mass spectrometer (ICP-MS; PerkinElmer, Shelton, CT). Quantification of Se was performed by the standard addition method, using a 4-point standard curve. A quality control sample (in similar matrix) was analyzed after every 5 samples, and analysis was considered acceptable if the Se concentration of the quality control sample fell within ±5% of the standard or reference value for the quality control.
Data Analysis
The 3-component mathematical model that best fit and described the kinetics of Se in the blood and serum were derived for the individual lambs using the curve stripping method. Because 3 lambs dosed with sodium selenate died before obtaining complete kinetic data, their data were removed from the data analysis. The kinetic evaluations were performed using PK Solutions 2.0 software (PK Solutions 2.0 for Noncompartmental Pharmacokinetic Data Analysis, Summit Research Services, Montrose, CO). The Se concentrations of the whole blood and serum from each sheep were individu- where Conc was the concentration of Se in serum or whole blood at a given time (t). The letters A, D, and E designated the y-axis (t = 0) intercepts and α, δ, and ε represented the rate constants for absorption, disposition or distribution, and elimination, respectively. Curve stripping was performed to calculate the intercepts and rate constants. Each curve was stripped in this order: 1) elimination phase, 2) disposition/distribution phase, and 3) absorption phase. Stripping involved mathematical subtraction of each term from the remaining expression to isolate and determine the individual linear constants associated with each phase.
Statistical Analysis
The data were analyzed as a completely random design; sodium selenate and MeSeCys were compared between compounds at equimolar doses and comparisons were made within compounds at increasing doses. These variables were determined and analyzed for statistical significance: absorption half-life (A 1/2 ), disposition or distribution half-life (D 1/2 ), elimination half-life (E 1/2 ), absorption rate constant (k a ), disposition/distribution rate constant (k d ), elimination rate constant (k e ), observed peak concentration (C max ), time to observed peak concentration (T max ), and area under the curve (AUC) determined using the trapezoidal method on a concentration vs. time graph from 0→Y. Treatment effects of sodium selenate and MeSeCys on kinetic variables were analyzed using a linear mixed model procedure (Proc Mixed; SAS Inst. Inc., Cary, NC) with animal as a random factor in the model. Least square means were calculated, and treatment means were separated after a significant F test (P < 0.05) using the probability of difference (PDIFF) procedure in SAS.
RESULTS
Between 18 and 24 h into the study, 3 lambs (1 lamb dosed with 2 mg Se/kg BW and 2 lambs dosed with 4 mg Se/kg BW as sodium selenate) became lethargic with a drooped head and dyspnea seen as wheezing and respiratory grunts. These animals were quickly euthanized and the data collected from the early time points were removed from the data analysis. Several other lambs developed much less severe clinical signs that were mainly characterized as reluctance to move and anorexia. The Se concentrations in serum and whole blood of lambs, at specific time points after oral dosing with increasing doses of sodium selenate and MeSeCys, are shown in Fig. 1 and 2, respectively. The Se concentrations in serum and whole blood, for both forms of Se, followed a simple dose-dependent relationship and increased linearly with dose as shown in Fig. 3 .
Serum
The mean ± SE for C max , T max , AUC, A 1/2 , D 1/2 , and E 1/2 for Se in serum of sheep dosed with sodium selenate and MeSeCys are reported in Table 2 .
Observed Peak Concentration. There was a dosedependent difference in the C max of Se in serum of lambs dosed with sodium selenate (P < 0.0001) and MeSeCys (P < 0.0001). The C max of Se in serum was greater Figure 1 . Oral dose kinetics of Se in serum of lambs dosed with increasing concentrations of Se. Data represents the mean Se concentration in serum of lambs (n = 4, except the groups dosed with sodium selenate at 2 and 4 mg Se/kg BW which had a n = 3 and n = 2, respectively) dosed with A) sodium selenate and B) Se-methylselenocyteine (MeSeCys) at specific time points postdosing.
(P < 0.0001) in lambs dosed with sodium selenate as compared with lambs dosed with MeSeCys at equimolar doses. There were differences in C max between the different chemical forms at doses of 2, 3, and 4 mg Se/kg BW (P < 0.0001, P < 0.0001, P = 0.004, respectively), whereas at 1 mg Se/kg BW there was not a difference (P = 0.31).
Time to Observed Peak Concentration. As the dose increased, the T max increased (P = 0.023) in lambs treated with sodium selenate. There were no dose-dependent differences in T max in serum of lambs dosed with MeSeCys. There was a difference (P = 0.0012) in T max of lambs dosed with sodium selenate and MeSeCys at equimolar doses. Lambs dosed with Se as MeSeCys at 1, 2, and 4 mg Se/kg BW reached T max in serum sooner than those treated with sodium selenate at equimolar doses (P = 0.051, 0.038, and 0.0013, respectively) whereas there was no difference in lambs dosed with 3 mg Se/kg BW (P = 0.14).
Area Under the Curve. There was a dose-dependent increase in AUC of Se in serum of lambs dosed with sodium selenate (P = 0.0002) and MeSeCys (P = 0.023). However, when comparing AUC of the different chemical forms of Se at equimolar doses, there were no differences in serum (P > 0.07).
Absorption Half-Life. There was a dose-dependent increase in the A 1/2 of Se in serum of lambs dosed with increasing doses of both sodium selenate (P = 0.0003) and MeSeCys (P = 0.0003). There was a difference (P < 0.0001) in the A 1/2 of Se in serum of lambs dosed with sodium selenate and MeSeCys at equimolar doses. At each dose the Se from MeSeCys was absorbed into the serum at a rate that was 4 to 5 times faster than Se from sodium selenate. The k a in serum of lambs dosed with sodium selenate ranged from 0.23 ± 0.02 at a dose of 4 mg Se/kg BW to 0.42 ± 0.04 at a dose of 1 mg Se/kg BW.
The k a for MeSeCys ranged from 0.93 ± 0.07 at a dose of 4 mg Se/kg BW to 1.8 ± 0.2 at a dose of 1 mg Se/kg BW.
Disposition or Distribution Half-Life. The D 1/2 of Se increased as the MeSeCys dose increased (P = 0.017). There was not a (P = 0.23) dose effect for the D 1/2 of Se in serum of lambs dosed with sodium selenate; however, the D 1/2 did increase as the dose increased. There were no differences when comparing the D 1/2 of Se in serum of lambs dosed with MeSeCys and sodium selenate at equimolar doses (P = 0.066). The k d of Se in serum of lambs dosed with sodium selenate ranged from 0.032 ± 0.003 at a dose of 4 mg Se/kg BW to 0.054 ± 0.007 at a dose of 1 mg Se/kg BW. The k d in serum of lambs dosed with MeSeCys ranged from 0.040 ± 0.004 to 0.071 ± 0.004.
Elimination Half-Life. Increasing of the dose of both sodium selenate and MeSeCys in lambs decreased the E 1/2 (P = 0.0051 and 0.042, respectively) of Se in serum. There was a difference between the chemical forms at equimolar doses of 2 mg Se/kg BW (P = 0.0005). As the dose increased from 1 to 4 mg Se/kg BW, the E 1/2 decreased 171 h for lambs dosed with sodium selenite, but only 127 h for lambs dosed with MeSeCys.
Whole Blood
The mean ± SE for C max , T max , AUC, A 1/2 , D 1/2 , and E 1/2 for Se in whole blood of sheep dosed with sodium selenate and MeSeCys are reported in Table 3 .
Observed Peak Concentration. There was a dosedependent difference in the C max of Se in whole blood of lambs dosed with sodium selenate (P < 0.0001) and MeSeCys (P < 0.0001). The C max of Se in whole blood was greater (P < 0.0001) in lambs dosed with MeSeCys when compared with those treated with sodium selenate Figure 2 . Oral dose kinetics of Se in whole blood of lambs dosed with increasing concentrations of Se. Data represents the mean Se concentration in whole blood of lambs (n = 4, except for groups dosed with sodium selenate at 2 and 4 mg Se/kg BW which had a n = 3 and n = 2, respectively) dosed with A) sodium selenate and B) Se-methylselenocyteine (MeSeCys) at specific time points postdosing.
at equimolar doses. There were differences between the 2 chemical forms at doses of 3 and 4 mg Se/kg BW (P = 0.0012, P < 0.0001, respectively), whereas at doses of 1 and 2 mg Se/kg BW there was not a difference (P = 0.64 and P = 0.49, respectively).
Time to Observed Peak Concentration. There was no statistical dose-dependent difference (P = 0.070) in the T max of Se in whole blood of lambs dosed with increasing doses of sodium selenate. However, there was a difference (P = 0.019) in T max with increasing doses of MeSeCys. The T max was greater in lambs dosed with sodium selenate than those dosed with MeSeCys at each dose [1 mg Se/kg BW (P = 0.0002), 2 mg Se/kg BW (P < 0.0001), 3 mg Se/kg BW (P < 0.0001), and 4 mg Se/kg BW (P < 0.0001)]. . Selenium concentrations in serum and whole blood of lambs dosed with 1, 2, 3, or 4 mg Se/kg BW as sodium selenate or Se-methylselenocysteine (MeSeCys). Data represents the mean ± SD Se concentration, of 4 lambs per group (except for groups dosed with sodium selenate at 2 and 4 mg Se/kg BW which had a n = 3 and n = 2, respectively), in A) serum at 30 min postdosing; B) whole blood at 30 min postdosing; C) serum at 2 h postdosing; D) whole blood at 2 h postdosing; E) serum at 168 h postdosing; F) whole blood at 168 h postdosing.
Area Under the Curve. There was a dose-dependent increase in AUC of Se in whole blood of lambs dosed with increasing doses of sodium selenate (P = 0.032) and MeSeCys (P < 0.0001). At equimolar doses of 2, 3, and 4 mg Se/kg BW, the AUC between the 2 chemical forms were different (P = 0.033, P < 0.0001, and P = 0.0008, respectively) and approximately twice as large in whole blood of lambs dosed with MeSeCys as compared with whole blood of lambs dosed with sodium selenate. At a dose of 1 mg Se/kg BW, there was not a difference (P = 0.35) between the 2 compounds in the AUC.
Absorption Half-Life. Increasing both the sodium selenate and MeSeCys doses increased the A 1/2 of Se (P = 0.0064 and 0.025, respectively). The different chemical forms of Se had very different (P < 0.0001) A 1/2 values at equimolar doses. The MeSeCys was absorbed 9.4 to 14.3 times faster than the sodium selenate. The k a of Se in whole blood of lambs dosed with sodium selenate ranged from 0.22 ± 0.01 at a dose of 4 mg Se/kg BW to 0.38 ± 0.03 at a dose of 1 mg Se/kg BW. The k a of Se in whole blood of lambs dosed with MeSeCys ranged from 2.5 ± 0.3 at a dose of 4 mg Se/kg BW to 3.6 ± 0.6 at a dose of 1 mg Se/kg BW.
Disposition or Distribution Half-Life. The D 1/2 of Se in whole blood of lambs trended upward as the dose of sodium selenate(P = 0.13) or MeSeCys (P = 0.16) increased; however, the changes were not significant, nor were there differences when comparing the D 1/2 of Se in whole blood of lambs dosed with equimolar doses of sodium selenate and MeSeCys. The K d for sodium selenate ranged from 11.7 ± 1.7 to 22.2 ± 0.2 h. The D 1/2 for MeSeCys ranged from 11.9 ± 1.5 to 17.0 ± 1.0 h.
Elimination Half-Life. There was a dose-dependent increase in E 1/2 of Se in whole blood of lambs dosed with MeSeCys (P = 0.039), however there was not a dose-dependent effect on E 1/2 in whole blood of lambs dosed sodium selenate (P = 0.15). Additionally there were no differences (P = 0.030) when comparing the E 1/2 of Se in whole blood of lambs dosed MeSeCys and sodium selenate at equimolar doses, except for at a dose of 1 mg Se/kg BW (P = 0.0007).
DISCUSSION
Previous research of Se toxicokinetics in sheep was focused on rates of elimination of Se after parenteral injections (Blodgett and Bevill, 1987) . Most of the experimental data were completed using sodium selenite, which is absorbed and metabolized differently from other selenocompounds. During the past decade, selenate and MeSeCys were identified as 2 of the most abundant chemical forms of Se in Se-accumulator plants (Pickering et al., 2000 (Pickering et al., , 2003 Freeman et al., 2006) . Cattle and sheep can be acutely poisoned after ingesting Se-accumulating plants with several thousand mg Se/kg from reclaimed mining areas (Fessler et al., 2003; Tiwary et al., 2007; Davis et al., 2012) or other ranges (Beath et al., 1932) . Many factors affect Se toxicosis, including animal species, age of animal, nutritional status, chemical form of Se, and route of Se exposure. The LD 50 for selenite given orally has been estimated to be 1.9 to 8.3 mg/kg BW in ruminants (Grace, 1994) . In a study using 8-to 12-wk-old lambs, half of the lambs administered either 6 or 8 mg Se/kg BW as SeMet became moribund and were euthanized (Tiwary et al., 2006) . Injectable Se is more acutely toxic than oral administration, with an intramuscular LD 50 of 0.5 mg/kg BW in lambs (Caravaggi et al., 1970) . In an acute toxicity study using male Kunming mice, the LD 50 of MeSeCys was determined to be 14.6 mg Se/kg BW, wile Nano-Se was determined to be 92.1 mg Se/kg BW (Zhang et al., 2008) . However, there does not appear to be any literature regarding the dosing of MeSeCys in large animals by any method, nor are there for the oral dosing of selenate at toxic doses. Therefore, the purpose of this study was to determine the kinetics of sodium selenate and MeSeCys orally dosed to 211.3 ± 25.4 b 2.06 ± 0.18* c 3.8 ± 0.3* *Kinetic variables that differ between treatments of different selenocompounds at equimolar doses (P < 0.05). a-c Within a column, kinetic variables that differ between treatments of the same selenocompound have different superscript letters (P < 0.05).
lambs at doses similar to Se concentrations ingested in cases of acute poisoning.
In this study, we dosed lambs with 1, 2, 3, or 4 mg Se/kg BW in an attempt to obtain sublethal doses similar to those expected for sheep when grazing on Se-accumulator plants. For example, a 30 kg lamb grazing Se accumulator plants containing 1,000 mg Se/kg would only need to eat 0.06 kg (dry weight) or 0.2% of his BW to ingest a potentially toxic dose of 2 mg Se/kg BW. Plants growing on seleniferous soils often contain 3,000 to 5,000 mg Se/kg. If plants contained 5,000 mg Se/kg, the sheep would only need to ingest about 12 g (dry weight), which is less than a handful of plant to obtain a potentially lethal dose.
In the present study, after orally dosing the selenocompounds, the C max of Se in serum was greater in lambs dosed with sodium selenate than those dosed MeSeCys at equimolar doses; however, T max in serum was obtained much sooner in lambs dosed with MeSeCys. In contrast, the C max in whole blood was much greater in lambs dosed MeSeCys than those given equimolar doses of sodium selenate, and T max in whole blood was reached faster in lambs dosed with MeSeCys as well. The absorption of Se from dosed MeSeCys occurred faster than Se dosed as sodium selenate. At the first collection point (10 min postdosing) the Se concentration in serum and whole blood of lambs orally dosed with 3 and 4 mg Se/kg BW as MeSeCys were 4.6 to 5.0 times greater than the Se concentration predosing. Conversely, the Se concentration in serum and whole blood of lambs dosed with 3 and 4 mg Se/kg BW as sodium selenate were only 1.1 to 1.2 times greater at 10 min postdosing than the Se concentration predosing. These results lead us to propose that some of the MeSeCys dose is absorbed directly from the rumen. These results differ from previous reports, which suggest the majority of ingested Se compounds are absorbed from the duodenum, with lesser amounts in the jejunum and ileum (Wright and Bell, 1966; Whanger et al., 1976) . It is generally believed that little to no absorption of Se occurs from the stomach and rumen. However, 1 report did suggest that a small amount of SeMet may be absorbed through the rumen wall (Hidiroglou and Jenkins, 1973) . It is known that the chemical form of Se greatly impacts overall absorption. For example, selenite absorption is via passive diffusion through the brush border membranes (Vendeland et al., 1992 (Vendeland et al., , 1994 . In contrast, selenate has little affinity for passive absorption. Selenate is absorbed via a sodium co-transport system that is also used by sulfate (Wolffram et al., 1988) . Selenium in the form of seleno-AA, SeMet and SeCys, is absorbed through the same active AA transport mechanisms as methionine and cysteine. Consequently, they are more bioavailable than selenite or selenate (McConnell and Cho, 1967; Ammerman and Miller, 1975; Vendeland et al., 1994; Sunde, 1997) .
We found that MeSeCys was rapidly absorbed into serum and whole blood; however, only a small portion of the total dose was detected in whole blood at C max . If we assume that whole blood constitutes 7% of the BW of sheep (Hidiroglou and Jenkins, 1973) and use the following formula where t = time:
% of dosed Se in whole blood at t x = [0.07 L/kg (blood Se at t x − blood Se at t 0 )]/dose, then, on average, 3.8 and 6.5% of the Se administered at doses of 1 and 4 mg Se/kg BW, respectively, were in whole blood of sheep dosed with MeSeCys at C max . With increasing doses of sodium selenate and MeSeCys, the amount of Se present in the whole blood at C max , as a percentage of the total oral dose, tended to increase. However, as absorption and elimination are continuously occurring from the time of dosing throughout the elimination period, it is not possible to estimate total oral bioavailability from this study, but we can compare dosages and chemical forms of the different Se compounds 17.0 ± 1.0 202 ± 4 a 607.5 ± 99.9* c 2.98 ± 0.34* c 3.5 ± 0.5* ab *Variables that differ between treatments of different selenocompounds at equimolar doses (P < 0.05). a-c Within a column, kinetic variables that differ between treatments of the same selenocompound have different superscript letters (P < 0.05).
at specific points in time. To determine how much of the total dose of the Se was absorbed into the animal, one would need to determine the Se concentrations in other tissues at various time points.
Based on whole blood kinetic analyses, Se absorbed from MeSeCys had a greater relative bioavailability than that of sodium selenate at equimolar Se doses. At each time point, Se concentration in whole blood was greater in sheep dosed with MeSeCys. Even at 168 h postdosing, the Se concentration in whole blood of sheep dosed with 4 mg Se/kg BW as MeSeCys remained at 1.24 ± 0.30 mg Se/kg, whereas the Se concentration in whole blood of sheep dosed an equimolar dose of sodium selenate was 0.48 ± 0.01 mg Se/kg. Whereas, the Se concentration in serum of sheep dosed with MeSeCys and sodium selenate were 0.33 ± 0.07 and 0.33 ± 0.04 mg Se/kg at 168 h postdosing, respectively. Additionally, the AUC was nearly twice as large in whole blood of sheep dosed with MeSeCys compared with lambs dosed sodium selenate at equimolar doses.
After absorption, inorganic Se is reduced to selenide. Organic selenocompounds are transformed into selenide via several different routes; selenocysteine (SeCys) is transformed to selenide by a β-lyase reaction, whereas SeMet can be transformed by the β-lyase reaction after the successive transselenation reaction to SeCys or directly through the γ-lyase reaction (Birringer et al., 2002; Suzuki, 2005) . The MeSeCys is very similar to SeCys and SeMet in structure however the potential mechanism of transformation to selenide has not been determined. It is assumed to be transformed into methylselenol through the β-lyase reaction and then demethylated to form selenide. Selenium reduced to selenide in red blood cells is known to be excreted into plasma and bound to albumin (Shiobara and Suzuki, 1998) . In our study, the difference in whole blood concentrations of selenate versus MeSeCys, together with the fact that the serum concentrations did not differ, verify a differential relative affinity for red blood cells, with more MeSeCys accumulating into red blood cells than selenate. A recent report by Imai et al. (2009) demonstrated that selenocysteine was selectively taken up by red blood cells but was not metabolized to selenide, whereas selenite was taken up by red blood cells then reduced to selenide and deposited in the plasma. Because MeSeCys is very similar in structure to selenocysteine, it may have a similar affinity for red blood cells and may not be reduced to selenide and subsequently moved out of red blood cells.
When comparing equimolar doses the sheep dosed with MeSeCys had larger C max in whole blood at all 4 doses, however the C max was greater in serum of sheep at all doses of sodium selenate. This difference in serum Se concentration may at least partially explain why selenate was relatively more toxic and 3 lambs dosed with sodium selenate developed severe clinical signs and were euthanized. Selenium in serum is more available and therefore has a greater potential effect to other tissues than is the Se inside red blood cells.
In conclusion, the results presented in this study demonstrate that there are significant differences between the kinetics of different selenocompounds when orally dosed to sheep. Because Se status is most commonly determined by blood analysis, in cases of acute selenosis it is important to understand the chemical form to which an intoxicated animal was exposed when determining the significance and meaning of Se concentration in serum or whole blood obtained at various times postexposure. This study also highlights the facts that differing chemical forms of Se are might have different absorptive routes from the gastrointestinal system and they appear to have different compartmentalization in blood. Based on the results of this study, it is likely that other chemical forms of Se also have unique toxicokinetic characteristics.
